| CF | Colony-forming |
| DDR | DNA damage response |
| UVC | ultraviolet light-C |
| ER | endoplasmic reticulum |
| UPR | unfolded protein response |
| OCT | organic cation transporter |
| MRP1/2 | multidrug resistance-associated proteins 1 and 2 |
| GSH | glutathione |
| MDR1 | multidrug resistance protein 1 |
| GST | GSH-S-transferase |
| PPC | pentose phosphate cycle |
| TrxR | thioredoxin reductase |
| Trx | thioredoxin |
| Nrf2 | nuclear erythroid-like factor 2 |
| ROS | reactive oxygen species |
| NER | nucleotide excision repair |
| FA | Fanconi anemia |
| CSC | cancer stem cells |
| WT | wild type |
| MDM2/4 | murine double minute 2 and 4 homologues |
| ATM | ataxia telangiectasia-mutated |
| ATR | ataxia telangiectasia and Rad3-related |
| Chk1/2 | checkpoint kinase 1 and 2 |
| DSB | DNA double-strand break |
| BAX | BCL-2-associated X |
| PUMA | p53 up-regulated modulator of apoptosis |
| BCL-2 | B-cell lymphoma 2 |
| TIGAR | p53-induced glycolysis and apoptotic regulator |
| GLS2 | glutaminase 2 |
| ABC | ATP-binding cassette |
| HO-1 | heme oxygenase-1 |
| TCS | therapy-induced cell senescence |
| SA-β-gal | senescence-associated β-galactosidase |
| PGCC | polyploid giant cancer cell |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide |
| EMT | epithelial to mesenchymal transition |
| WIP1 | wild-type p53-induced phosphatase 1 |
| JNK | jun N-terminal kinase |
| IAP | inhibitor of apoptosis protein |
| BCL-XL | B-cell lymphoma-extra large |
| mTOR | mammalian target of rapamycin |